Related Experiment Video
Updated: Sep 10, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Lorlatinib Achieved Rapid CNS Response in an 81-Year-Old NSCLC Patient With Performance Status Deterioration
Akina Nigi1, Keisuke Iwamoto1, Hidetoshi Itani1
1Department of Respiratory Medicine Japanese Red Cross Ise Hospital Ise Mie Japan.
Abstract:
Lorlatinib may offer rapid CNS symptom and imaging improvement after alectinib failure, even in elderly ALK-positive NSCLC patients with declining performance status.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11:09Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
Published on: July 13, 2010